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Background: Competition of probiotic bacteria with other species from the intestinal microbiota involves
different mechanisms that occur regardless of probiotics’ viability. The objective of this paper was to assess
the cytokine serum levels in holoxenic mice after oral administration of non-viable components (NVC) of
Enterococcus faecium probiotic culture stimulated with heat-inactivated Escherichia coli and Bacillus cereus in
comparison to NVC of unstimulated E. faecium probiotic culture.
Methods: Probiotic E. faecium CMGb 16 culture, grown in the presence of heat-inactivated cultures of E. coli
and B. cereus CMGB 102, was subsequently separated into supernatant (SN) and heat-inactivated cellular
sediment (CS) fractions by centrifugation. Each NVC was orally administered to holoxenic mice (balb C
mouse strain), in three doses, given at 24 hours. Blood samples were collected from the retinal artery, at 7, 14,
and 21 days after the first administration of the NVC. The serum concentrations of IL-12 and tumor necrosis
factor-alpha (TNF-a) interleukins were assessed by ELISA method.
Results: After the oral administration of SN component obtained from the probiotic culture stimulated with heat-
inactivated cultures of B. cereus CMGB 102 and E. coli O28, the serum concentrations of IL-12 were maintained
higher in the samples collected at 7 and 14 days post-administration. No specific TNF-a profile could be
established, depending on stimulated or non-stimulated probiotic culture, NVC fraction, or harvesting time.
Conclusion: The obtained results demonstrate that non-viable fractions of probiotic bacteria, stimulated by
other bacterial species, could induce immunostimulatory effects mediated by cytokines and act, therefore, as
immunological adjuvants.
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D
ual action of probiotics is manifested both on the
microbiota and the host organism. The interac-
tion of viable probiotic bacteria with other
membersofintestinalmicrobiota,achievedbycompetitive
exclusion (competition for nutrients and adhesion sites)
and the synthesis of inhibitory molecules is very well
documented (1). The interaction of non-viable probiotics
fractions with the host organism is less studied (2).
However, dead probiotic cells could still adhere to specific
epithelial cell receptors and stimulate MALT (mucosal
lymphoid associated tissue) structures, triggering a local
immune response (1).
Therefore, both live and dead probiotic cells and sub-
cellular fractions can generate beneficial biological re-
sponses, raising the necessity to elucidate their intimate
mechanisms of action and, respectively, the benefits and
the potential side effects in each case.
It has been shown that the probiotic cells are producing
antimicrobial substances, but also quorum sensing inhibi-
tors (QSIs) which are interfering with the pathogens QS
mechanisms andwith their virulence genes expression (3).
For example, lactic acid bacteria synthesize bacteriocins
depending on the cellular density, using a QS regulatory
mechanism, which requires an extracellular accumulation
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(page number not for citation purpose)of autoinductor peptides (AI2) that function as chemical
messengers (4, 5). There are experimental evidences that
the probiotic supernatants (SN), which contain antimi-
crobial molecules and QS signal molecules, can influence
the growth and virulence features expression of some
EAggEC (Enteroaggregative Escherichia coli) clinical
strains (6, 7).
It has been widely demonstrated that probiotics
represent a potential effective alternative in the treatment
of inflammatory and auto-immune gastrointestinal dis-
eases due to their beneficial effects in modulating the
immune response (810). However, the administration of
viable bacterial cells to individuals with weaker immune
systems, enhanced inflammatory responses, and/or com-
promised mucosal barrier functions could turn from
‘generally recognized as safe’ harmless probiotic bacteria
into detrimental ones (11).
Therearealso some resultsshowing that gut microbiota
and even some bacterial probiotics could be involved in
human obesity, for example, when microbiota is enriched
in M. smithii (12, 13) or depleted in this archaeal species;
in this last case, some Bifidobacterium or Lactobacillus
species were associated with normal weight (B. animalis)
while others (L. reuteri) were associated with obesity (14).
Probiotic cell components associated with in vitro
immunomodulatory properties include entire cell wall
(15) or some components as lypoteichoic acids (16) and
S-layer proteins (17), or even bacterial DNA (18, 19).
Some clinical studies have also suggested that non-viable
probiotic fractions can modulate the human immune
system, for example, by enhancing secretory IgA produc-
tion (20) and by modulating host T-cell responses (21)
and gene expression (22). In a limited number of in vitro
and animal studies that have directly compared the effects
of viable and inactivated probiotics on innate immunity,
these have been found to be equally effective (2325).
There are some evidences that modulation of inflam-
matory response, as revealed by cytokine profiles, is an
important mechanism by which probiotics provide health
benefits (26). For instance, it has been shown that cell
surface molecules of Lactobacillus sp. strains could elicit
strong tumor necrosis factor-alpha (TNF-a) inducing
activities in macrophages through Toll-like receptor 2
(16). In addition, the antimicrobial defensins, cathelici-
dins, eosinophil-derived neurotoxin, and AI-2 signa-
ling compounds of Gram-positive and Gram-negative
bacteria play important roles in intra- and interspecies
communication (5, 27).
For some bacterial species, the viability is not necessary
to induce cytokine production (28), the components of
dead cells being also able to induce an anti-inflammatory
response in the gastrointestinal tract (2). Dead bifido-
bacteria induce significant increases in TNF-a produc-
tion (29). It was also demonstrated that heat-killed cells
of E. faecalis stimulate the gastrointestinal immune
system in chickens (30), while administration in healthy
dogs increases neutrophil phagocytes number (31). Based
on these observations, it could be stated that probiotic
bacteria (as viable cells or non-viable fractions) can act as
immunomodulators.
In this context, the objective of this paper was to assess
the cytokine serum levels in holoxenic mice after oral
administration of non-viable components (NVC) of
Enterococcus faecium probiotic culture stimulated with
heat-inactivated E. coli and Bacillus cereus in comparison
to NVC of unstimulated E. faecium culture.
Material and methods
Bacterial strains and growth conditions
Probiotic strain E. faecium CMGB16 (isolated from
infant faeces) was cultivated in anaerobic conditions, in
MRS broth. Enteropathogenic E. coli O28 (provided by
National Institute of Research and Development for
MicrobiologyandImmunology‘Cantacuzino’,Bucharest)
and B. cereus CMGB 102 (Microbial culture collection of
Facultyof Biology, Microbiology Department, University
of Bucharest) strains were grown in nutrient broth.
NVC obtaining
E. faecium CMGB16 was co-cultivated in the presence of
heat-inactivated cultures of E. coli O28 and B. cereus, for
24hoursinMRSbroth(ManRogosaSharp),inanaerobic
conditions, at 378C. The co-cultivation method was
performed by inoculating 4 ml MRS broth with 40 mlo f
fresh E. faecium CMGB16 culture corresponding to
standard McFarland 1 (310
8 CFU/ml) and 400 mlo f
heat-inactivated cultures of E. coli O28/B. cereus corre-
sponding to standard McFarland 1 (310
8 CFU/ml),
before inactivation. The heat-inactivation was performed
by autoclaving the bacterial cultures at 1218C for 15 min.
After co-cultivation, the NVC components (SNs and
cellular fraction) were separated by centrifugation (6,000
rpm, 10 min). The cellular sediment was adjusted to
McFarland1(310
8CFU/ml)densityinPBS(Phosphate
Buffer Saline) and along with integral cultures (IC) was
heat-inactivated for 15 min at 1218C. Heat-inactivated
cellular suspensions obtained from the cellular sediments
(CS), the IC, and the SN were further used for the
immunomodulatory activity assay.
Immunomodulatory properties of the obtained NVCs
were tested on holoxenic mice (BALB/c mouse strain).
Each NVC was orally administered (by using a gradate
pipette) in three doses of 0.2 ml/dose to three animals/
sample, at 24 hours. Blood samples were collected from
the retinal artery, by the non-traumatizing retro-orbital
puncture method in the inner corner of the eye. Blood
samples were collected after 7, 14, and 21 days from the
first administration of the heat-inactivated probiotic
fractions.
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leukins were assessed by ELISA method, using Mouse
ELISA Kit Thermo Scientific (Pierce Biotechnology,
Rockford, UAS), following the manufacturers’ instruc-
tions. All experiments were performed in triplicates and
absorbance was measured on Apollo LB 911 ELISA plate
reader set at 450 and 550 nm. A standard curve was
generated by plotting the average absorbance obtained for
eachStandardconcentrationonthevertical(Y)axisvs.the
corresponding IL 12/TNF-a concentration (pg/ml) on the
horizontal (X) axis. Using the standard curve, the IL-12/
TNF-a amount in each sample was determined by inter-
polating the absorbance values (Y-axis) to IL-12/TNF-a
concentration. In this way, the absorbance results were
converted in pg/ml concentrations. These values were
plotted on graphs presented in the Results and discussions
section.SensitivityofIL12MouseELISAkitwas B12pg/
ml and the sensitivity of TNF-a Mouse ELISA kit was
B9 pg/ml.
Results and discussions
The majority of scientific studies use the term probiotic
according to the FAO/WHO (Food and Agriculture
Organization of the United Nations/World Health Orga-
nization) (32) definition, i.e. live microorganisms, which
when administered in adequate amounts could confer
a health benefit on the host. Therefore, this definition
requires that the probiotic must be viable, with many
studies supporting this idea (3336).
However, there are some scientific findings supporting
the positive effects of the probiotic NVCs on health due
to the ability of human immune cells to recognize specific
bacterial components and metabolic by-products, gener-
ating an immunomodulatory effect that involves MALT
activation (2). Chuang (37) showed that three heat-killed
strains of Lactobacillus sp. modulated the immune res-
ponses by stimulating proliferation of murine spleno-
cytes. In addition, these heat-killed probiotic cells also
induced high levels of IL-12 p70 in dendritic cells of mice
and the switch to a T helper 1 (Th1) immune response.
Given the complexity of the phenomena induced by
viable and non-viable probiotics, Taverniti (38) has
proposed the term ‘paraprobiotic’ defined as non-viable
fractions of probiotic origin (inactivated microbial cells
or cell fractions), which have been demonstrated to
positively affect human/animal health. The study of these
paraprobiotics is justified by the opinion of some authors
that probiotics could be involved in obesity/metabolic
syndrome (39); simultaneously, the specific effects of
probiotic components/culture fractions and targets are
important to be known in order to define appropriate
clinical applications (similarly to the modern, subunitary
vaccines or to immunomodulators). During this study we
have used probiotic culture fractions stimulated with
other inactivated bacterial cultures, to mimic the inter-
species interactions established in the intestinal mucosa.
In order to include both probiotic and stimulating
bacterial culture components found in the final fractions,
we propose the term ‘parabiotic’, defined as NVC of
microbial origin that exhibit beneficial effects on the
health of the human or animal host organism.
The serum samples collected after 7, 14, 21 days from
the first administration of probiotic fractions were
analyzed for IL-12 and TNF-a serum levels by ELISA
method. The obtained values represent the average of the
determinations performed for each animal batch (Fig. 1).
The obtained results showed that the age of the
animals significantly influenced the serum concentration
of IL-12. The highest levels of IL-12 were recorded at
7 days after the first administration of the IC and SN
NVCs, especially those stimulated with B. cereus (Fig. 1).
At 14 and 21 days after the first oral administration
of probiotic NVCs, the serum concentration of IL-12
generally decreased. In exchange, after the oral adminis-
tration of SN component stimulated with B. cereus and
E. coli, the serum concentrations of IL-12 were main-
tained higher in the samples collected after 21 days post-
administration. These aspects suggest that B. cereus and
E. coli strains stimulate the synthesis and accumulation in
the probiotic cultures SN of bacterial molecules poten-
tially involved in the activation of mucosal intestinal
cells, such as macrophages or dendritic cells, to synthesize
IL-12. However, it is to be noticed that the unstimulated
fractions, particularly CS and SN, also induced high
levels of IL-12, especially at 7 and 14 days after the first
administration. IL-12 is a cytokine required for the
initiation of the immune response, constituting the
connecting bridge between non-specific defense reactions
(it activates macrophages and NK cells) and specific
immune response.
The production of immunomodulatory molecules by
probiotic bacteria is thus influenced by the presence of
other bacterial species, both Gram-positive and Gram-
negative, which inhabit the gut (autochthonous and
allochthonous microbiota), by complex and incompletely
understood cross-talk mechanisms. The induction of a
late immunostimulatory response by these soluble mole-
cules could suggest that they are resistant to digestive
enzymes degradation, and could slowly and gradually
diffuse in the submucosa, inducing the activation of
MALT. This effect was not evident after the adminis-
tration of CS and IC from the unstimulated NVCs,
supporting the hypothesis that the late immunomodula-
tory effect is due to small, heat-stable, soluble molecules.
Studies on peptide fractions (with molecular weight
between 2 and 10 Da) isolated from Lactobacillus
helveticus culture (using HPLC method) showed their
immunomodulatory effects after oral administration in
holoxenic mice infected with E. coli O157:H7 (40).
Cytokine profile of these mice revealed a stimulation of
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the B cells number in the intestine (lamina propria), and
thus the concentration of secretory IgA.
The scientific researches states that probiotics (either
viable cells or cellular fragments with antigenic potential)
must interact with MALT structures (dendritic cells, M
cells from the Peyer patches) to generate an immunosti-
mulatory effect, the route of antigen internalization being
essential for the initiation of an immune response in the
gastrointestinal mucosa (11, 28, 41). These observations
may explain why the early stimulation of IL-12 synthesis
at 7 days after the first administration was induced
mainly by the IC stimulated fraction, containing strong
particulate antigens.
Beingthedominantcytokineinvolvedinthematuration
of CD
4 T cells, IL-12 plays an important role in immu-
nomodulation, its synthesis being an essential process
Fig. 1. Graphic representation of IL-12 concentration in the
serum of holoxenic mice, collected after: I  7 days from the first
oral administration of NVCs; II  14 days from the first oral
administration of NVCs; III  21 days from the first oral
administration of NVCs. IC, integral culture; CS, cellular
suspension; SN, supernatant; A, serum collected from holoxenic
mice after oral administration of NVC; B, serum collected from
holoxenic mice after oral administration of NVC stimulated
with E. coli O28C; C, serum collected from holoxenic mice after
oral administration of NVC stimulated with B. cereus;M C ,
media control  serum collected from holoxenic mice after oral
administration of MRS; NC, negative control  serum collected
from holoxenic mice control.
Fig. 2. Graphic representation of TNF a concentration in the
serum of holoxenic mice, collected after: I  7 days from the first
oral administration of NVCs; II  14 days from the first oral
administration of NVCs; III  21 days from the first oral
administration of NVCs. IC, integral culture, CS, cellular
suspension; SN, supernatant; A, serum collected from holoxenic
mice after oral administration of NVC; B, serum collected from
holoxenic mice after oral administration of NVC stimulated
with E. coli O28C; C, serum collected from holoxenic mice after
oral administration of NVC stimulated with B. cereus; MC,
media control  serum collected from holoxenic mice after oral
administration of MRS; NC, negative control  serum collected
from holoxenic mice control.
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response to adjuvants (42).
In the case of TNF synthesis, the obtained results were
variable, no specific cytokine profile dependent on pro-
biotic NVCs,stimulating species,or serum harvestingtime
being identified. However, at all three harvesting intervals,
the highest levels of TNF were induced after the admini-
stration of the IC fractions stimulatedwith E. coli (Fig. 2).
After 7 days, the most intensive stimulating effect was
obtained for SN fraction stimulated with B. cereus, while
the un-stimulated CS fraction induced thehighest levels of
TNF at 14 and 21 days after administration.
This effect suggests again that the cellular fragments
with strong antigenic properties could induce the activa-
tion of macrophage cells from the sub-endothelial com-
partment (the main TNF producing cells). It has been
shown that both crude extracts and purified lipoteichoic
acids from L. casei and L. fermentum could significantly
induce TNF secretion by mouse splenic mononuclear cells
(16).Thissuggeststhatpurifiedlipoteichoicacidsmaybea
better candidate for clinical use than whole bacteria since
they do not contain other bacterial components which
might cause side effects (2).
TheinductionofTNF-asynthesisbyprobioticbacteria,
observed in many other studies (28) seems to be necessary
in order to establish functional connections between
intestinal epithelial cells and the immune cells (B cells,
dendritic cells, macrophages) from the lamina propria.
Conclusions
Our results, similar to other scientific studies, demonstrate
that inactivated soluble and cellular fractions of probi-
otic cultures, whose composition can be influenced by the
stimulation with other microbial species, could induce
immunomodulatory effects mediated by cytokines. Fur-
ther studies are required in order to identify the chemical
nature of these so-called parabiotic fractions.
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